No Data
No Data
Express News | Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 4.76 Million in Common Stocks
Argus Research Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $375
Leerink Partners Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $420
Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $432
United Therapeutics Analyst Ratings
H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $425
Unlock the Full List